The Apex Times
Above the Noise
Politics Wire
PoliticsFive years after U.S. withdrawal, Afghanistan exit anniversary highlights shift in refugee and parole pathwaysThe Apex TimesPoliticsRNC chair Joe Gruters warns Democratic House and Senate control could elevate “antisemites,” calling it a “direct threat to the Jewish community”The Apex TimesPoliticsTom Homan disputes claims of ICE arrests of parents at Connecticut school bus stopsThe Apex TimesPoliticsPresident Trump order renames Lake Ontario as “Lake America,” prompting Google Maps label change on U.S. phonesThe Apex TimesPoliticsReport says Birmingham authorities treated some English flag displays as public-order issues, while other flags were not targeted in the same wayThe Apex TimesPoliticsRahm Emanuel says Democratic Socialists of America are not part of Democratic PartyThe Apex TimesPoliticsWhite House posts order renaming Lake Ontario as “Lake America” as Google begins map updates, CBS News reportsThe Apex TimesPoliticsAdvocates accuse Trump EPA of altering safety-data conclusions for TBBPA, a flame retardant detected in homesThe Apex TimesPoliticsAbdul El-Sayed apologizes to Michigan Jewish Democratic Caucus for remarks tied to March synagogue attackThe Apex TimesPoliticsRoy Cooper campaign reframes data center growth around rising power costs in North Carolina Senate bidThe Apex TimesPoliticsAppeals court says South Carolina’s mail-in ballot age exemption violates the 26th Amendment as state seeks further reviewThe Apex TimesPoliticsWhite House posts on tariffs and Iran policy as NPR highlights mail-in voting order and Kushner-Jeffries meeting in election-cycle discussionThe Apex TimesPoliticsFive years after U.S. withdrawal, Afghanistan exit anniversary highlights shift in refugee and parole pathwaysThe Apex TimesPoliticsRNC chair Joe Gruters warns Democratic House and Senate control could elevate “antisemites,” calling it a “direct threat to the Jewish community”The Apex TimesPoliticsTom Homan disputes claims of ICE arrests of parents at Connecticut school bus stopsThe Apex TimesPoliticsPresident Trump order renames Lake Ontario as “Lake America,” prompting Google Maps label change on U.S. phonesThe Apex TimesPoliticsReport says Birmingham authorities treated some English flag displays as public-order issues, while other flags were not targeted in the same wayThe Apex TimesPoliticsRahm Emanuel says Democratic Socialists of America are not part of Democratic PartyThe Apex TimesPoliticsWhite House posts order renaming Lake Ontario as “Lake America” as Google begins map updates, CBS News reportsThe Apex TimesPoliticsAdvocates accuse Trump EPA of altering safety-data conclusions for TBBPA, a flame retardant detected in homesThe Apex TimesPoliticsAbdul El-Sayed apologizes to Michigan Jewish Democratic Caucus for remarks tied to March synagogue attackThe Apex TimesPoliticsRoy Cooper campaign reframes data center growth around rising power costs in North Carolina Senate bidThe Apex TimesPoliticsAppeals court says South Carolina’s mail-in ballot age exemption violates the 26th Amendment as state seeks further reviewThe Apex TimesPoliticsWhite House posts on tariffs and Iran policy as NPR highlights mail-in voting order and Kushner-Jeffries meeting in election-cycle discussionThe Apex TimesPoliticsFive years after U.S. withdrawal, Afghanistan exit anniversary highlights shift in refugee and parole pathwaysThe Apex TimesPoliticsRNC chair Joe Gruters warns Democratic House and Senate control could elevate “antisemites,” calling it a “direct threat to the Jewish community”The Apex TimesPoliticsTom Homan disputes claims of ICE arrests of parents at Connecticut school bus stopsThe Apex TimesPoliticsPresident Trump order renames Lake Ontario as “Lake America,” prompting Google Maps label change on U.S. phonesThe Apex TimesPoliticsReport says Birmingham authorities treated some English flag displays as public-order issues, while other flags were not targeted in the same wayThe Apex TimesPoliticsRahm Emanuel says Democratic Socialists of America are not part of Democratic PartyThe Apex TimesPoliticsWhite House posts order renaming Lake Ontario as “Lake America” as Google begins map updates, CBS News reportsThe Apex TimesPoliticsAdvocates accuse Trump EPA of altering safety-data conclusions for TBBPA, a flame retardant detected in homesThe Apex TimesPoliticsAbdul El-Sayed apologizes to Michigan Jewish Democratic Caucus for remarks tied to March synagogue attackThe Apex TimesPoliticsRoy Cooper campaign reframes data center growth around rising power costs in North Carolina Senate bidThe Apex TimesPoliticsAppeals court says South Carolina’s mail-in ballot age exemption violates the 26th Amendment as state seeks further reviewThe Apex TimesPoliticsWhite House posts on tariffs and Iran policy as NPR highlights mail-in voting order and Kushner-Jeffries meeting in election-cycle discussionThe Apex TimesPoliticsFive years after U.S. withdrawal, Afghanistan exit anniversary highlights shift in refugee and parole pathwaysThe Apex TimesPoliticsRNC chair Joe Gruters warns Democratic House and Senate control could elevate “antisemites,” calling it a “direct threat to the Jewish community”The Apex TimesPoliticsTom Homan disputes claims of ICE arrests of parents at Connecticut school bus stopsThe Apex TimesPoliticsPresident Trump order renames Lake Ontario as “Lake America,” prompting Google Maps label change on U.S. phonesThe Apex TimesPoliticsReport says Birmingham authorities treated some English flag displays as public-order issues, while other flags were not targeted in the same wayThe Apex TimesPoliticsRahm Emanuel says Democratic Socialists of America are not part of Democratic PartyThe Apex TimesPoliticsWhite House posts order renaming Lake Ontario as “Lake America” as Google begins map updates, CBS News reportsThe Apex TimesPoliticsAdvocates accuse Trump EPA of altering safety-data conclusions for TBBPA, a flame retardant detected in homesThe Apex TimesPoliticsAbdul El-Sayed apologizes to Michigan Jewish Democratic Caucus for remarks tied to March synagogue attackThe Apex TimesPoliticsRoy Cooper campaign reframes data center growth around rising power costs in North Carolina Senate bidThe Apex TimesPoliticsAppeals court says South Carolina’s mail-in ballot age exemption violates the 26th Amendment as state seeks further reviewThe Apex TimesPoliticsWhite House posts on tariffs and Iran policy as NPR highlights mail-in voting order and Kushner-Jeffries meeting in election-cycle discussionThe Apex Times
Back to front
FDA approves daraxonrasib pill for advanced pancreatic cancer, clearing new once-daily option
The Apex Times

THE APEX TIMES

Politics/The Apex Times/Aug 26, 2:15 PM EDT

FDA approves daraxonrasib pill for advanced pancreatic cancer, clearing new once-daily option

The Food and Drug Administration has approved daraxonrasib, a once-daily treatment for advanced pancreatic cancer marketed as Rasonque, according to The Hill. The approval covers patients whose disease has progressed after prior therapy.

2 min readEditor-approved Apex article

The Food and Drug Administration approved daraxonrasib, a new oral treatment for advanced pancreatic cancer, clearing a once-daily pill for patients who have already tried earlier options, The Hill reported on Wednesday. According to the report, the drug, developed by Revolution Medicines, will be sold under the brand name Rasonque. The approval is for a setting involving advanced pancreatic cancer and is described as providing new life-extending care for patients with one of the most aggressive forms of cancer, The Hill said. The Hill reported that daraxonrasib is administered as a once-daily pill rather than an infusion-based therapy, a practical change that can affect how care is delivered in oncology settings and how patients and clinicians schedule treatment around visits and other daily needs. The report states that the FDA’s approval is for patients who already tried prior treatment, but it does not detail in the provided packet which specific prior therapies were included in the approval criteria. The precise patient-eligibility language, dosing, and whether the approval covers particular tumor markers or line-of-therapy thresholds were not included in the supplied material. The FDA approval also raises questions about next-step access and implementation, including how quickly prescriptions are expected to reach oncology practices, how payers will set coverage terms, and what additional data clinicians will look for to determine how daraxonrasib fits into existing treatment sequencing for advanced pancreatic cancer. Revolution Medicines’ role in developing the therapy, and the FDA’s decision to approve the regimen, mark a new addition to the limited menu of treatments for advanced pancreatic cancer, The Hill said. As with other FDA approvals, post-marketing monitoring and updates to prescribing information typically follow, though details were not provided in the supplied record.

Why It Matters

  • An oral, once-daily option may change the day-to-day logistics of care for patients receiving treatment for advanced pancreatic cancer, depending on prescribing and administration guidelines.
  • The FDA approval expands the set of regulated therapies available to oncologists for advanced pancreatic cancer patients after prior treatment, potentially affecting treatment sequencing in practice.
  • Insurance coverage, prescribing adoption, and patient access are expected to be key near-term implementation issues after FDA approval, especially when eligibility criteria are specific.
  • Because the supplied packet does not include the FDA’s full indication language, clinicians and patients will need to review the official labeling to confirm eligibility and how the therapy fits within existing standards of care.

Sources

Key Facts

  • The FDA approved daraxonrasib, an oral once-daily pill, for advanced pancreatic cancer, The Hill reported.
  • The drug will be marketed under the brand name Rasonque, according to The Hill.
  • The approval is described as for patients who already tried earlier treatment options, The Hill reported.
  • The drug is manufactured by Revolution Medicines, according to The Hill.